$GERN Recent News Oracle active, Geron shares fall after

New Post Public Reply Private Reply Replies (0) Message Board

Nov 8, 2013 at 11:03 PM

$GERN Recent News

Oracle active, Geron shares fall after hours 6:06 p.m. Dec. 3, 2012 - Carla Mozee
Geron to discontinue brain-cancer drug development 4:38 p.m. Dec. 3, 2012 - MarketWatch.com
BioTime offers equity stake for Geron assets 8:47 a.m. Oct. 18, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 1:42 p.m. Sept. 10, 2012 - MarketWatch
Geron ends breast cancer study of Imetelstat 7:06 a.m. Sept. 10, 2012 - MarketWatch.com
Stocks to Watch Friday: Splunk, Zumiez, Pandora 3:59 p.m. Aug. 30, 2012 - David B. Wilkerson
Thursday’s biggest gaining and declining stocks 3:31 p.m. Aug. 30, 2012 - MarketWatch
Geron climbs 11% on analyst rating 9:56 a.m. Aug. 30, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:37 p.m. Nov. 15, 2011 - Kate Gibson
Financial uncertainty nixed Geron stem cell work 2:09 p.m. Nov. 15, 2011 - MarketWatch.com
Stocks to watch Friday: Global Crossing, Clarcor 5:42 a.m. Sept. 30, 2011 - MarketWatch
Court upholds stem-cell research funding: reports 10:46 a.m. July 27, 2011 - Val Brickates Kennedy
Are stem-cell stocks a good buy? 2:06 p.m. July 13, 2011 - Val Brickates Kennedy
Amylin and Alkermes shine in drug-stocks trading 2:08 p.m. July 8, 2011 - Val Brickates Kennedy
Stem-cell stocks rise on artificial-trachea report 1:57 p.m. July 8, 2011 - Val Brickates Kennedy
Regeneron, Cephalon boost biotech stocks 2:29 p.m. May 2, 2011 - Val Brickates Kennedy
Stem cell researchers gain on U.S. court decision 9:14 a.m. May 2, 2011 - Val Brickates Kennedy
StemCells shares climb on spinal injury study 2:49 p.m. March 14, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 3:09 p.m. Dec. 7, 2010 - Kate Gibson
Onyx buoys drug stocks; Geron plunges 1:54 p.m. Dec. 7, 2010 - Val Brickates Kennedy

Multiple Reasons To Buy Incyte 3:25 p.m. Today - Seeking Alpha
The 10 Dumbest Things This Friday 12:14 p.m. Today - 247WallSt.com
Geron's Promising News Poses No Threat To Incyte 11:53 a.m. Today - Seeking Alpha
Interesting GERN Put And Call Options For January 2015 11:08 a.m. Today - TheStreet.com
Geron Corporation (GERN) Is Today's Perilous Reversal Stock 9:46 a.m. Today - TheStreet.com
Key Issues Surrounding The Zalicus Catalyst Trade 8:56 a.m. Today - Seeking Alpha
Quick Take On Geron's Imetelstat Abstract 9:17 p.m. Nov. 7, 2013 - Seeking Alpha
Geron Management Discusses Q3 2013 Results - Earnings Call Transcript 7:10 p.m. Nov. 7, 2013 - Seeking Alpha
Geron Corporation Discusses Q3 2013 Results (Webcast) 4:25 p.m. Nov. 7, 2013 - Seeking Alpha
Geron Move Seems Hard To Interpret As Sustainable 3:08 p.m. Nov. 7, 2013 - 247WallSt.com
Geron Revealed Positive Imetelstat Results Amidst Data Concerns 12:10 p.m. Nov. 7, 2013 - benzinga.com
Facebook Tests Star-Rating System for Users and 2 Other Hot Stocks to Watch 11:41 a.m. Nov. 7, 2013 - Wall St. Cheat Sheet
Geron's Imetelstat Data in Myelofibrosis: 4 CRs, 1 PR. But Are These Responses Real? (Update) 10:04 a.m. Nov. 7, 2013 - TheStreet.com
Today's Dead Cat Bounce Stock Is Geron Corporation (GERN) 9:45 a.m. Nov. 7, 2013 - TheStreet.com
Geron: Super Important Imetelstat Data Coming Thursday 7:08 a.m. Nov. 5, 2013 - TheStreet.com
First Week Of June 2014 Options Trading For Geron (GERN) 11:28 a.m. Oct. 23, 2013 - TheStreet.com
Trade-Ideas: Geron Corporation (GERN) Is Today's "Perilous Reversal" Stock 9:45 a.m. Oct. 17, 2013 - TheStreet.com
Alcoa Says Ma’aden JV Smelter Shuts Down Potline and 2 More Heavily Traded Stocks to Follow 4:28 p.m. Oct. 16, 2013 - Wall St. Cheat Sheet
Geron Data from Myelofibrosis IST to be Presented at ASH Oral Session on December 9 -8K 5:47 a.m. Oct. 15, 2013 - benzinga.com
Biotech Stocks Fall Most in Two Years Amidst Debt Ceiling Fears 4:17 p.m. Oct. 8, 2013 - TheStreet.com

Earning Forecast Tips for Hot Stocks: Facebook, Tesla, J.C. Penney, Groupon, Geron, and Alcoa 9:00 a.m. Today - PR Newswire
TrendingWallStreet.com Initiates Volume Analysis on TWTR, FNMA, SEEK, and GERN 12:19 a.m. Today - ACCESSWIRE
Geron Corporation Reports Third Quarter 2013 Financial Results 4:11 p.m. Nov. 7, 2013 - Thomson Reuters ONE
WIN, VNDA, BIOS, GERN added to NASDAQ Active Stock Watch List at GSR 10:28 a.m. Nov. 7, 2013 - ACCESSWIRE
Geron Announces Conference Call to Discuss Third Quarter 2013 Financial Results 3:01 p.m. Nov. 1, 2013 - Thomson Reuters ONE
Pre-Market Review: Arena Pharma Inc., Geron Corp., Incyte Corp. Ltd, and Spectrum Pharma Inc. 8:00 a.m. Oct. 31, 2013 - PR Newswire
Divestiture, Clinical Study Updates, New Drug Application, and Quarterly Report - Research Report on Geron, NPS, Portola, MannKind, and Exact Sciences 7:00 a.m. Oct. 21, 2013 - PR Newswire
Early Briefing and Review: Arena Pharma Inc., Spectrum Pharma Inc., Incyte Corp. Ltd., and Geron Corp. 8:26 a.m. Oct. 8, 2013 - PR Newswire
TSLA, AGNC, GERN and ZLCS added to Nasdaq Active Stock Watch List at GSR 8:05 a.m. Oct. 1, 2013 - ACCESSWIRE
Geron Completes Divestiture of Stem Cell Assets 8:01 a.m. Oct. 1, 2013 - Thomson Reuters ONE
Asterias Biotherapeutics, Inc., a Subsidiary of BioTime, Inc., Acquires Geron's Embryonic Stem Cell Assets 8:00 a.m. Oct. 1, 2013 - BusinessWire
FSLR, LINE, GERN and CLDX added to NASDAQ Active Stock Watch List at EPR 8:05 a.m. Sept. 24, 2013 - ACCESSWIRE
Edge Therapeutics Elects Robert J. Spiegel, MD To Board of Directors 5:30 a.m. Sept. 10, 2013 - BusinessWire
Geron to Present at the Stifel Healthcare Conference 3:00 p.m. Sept. 4, 2013 - Thomson Reuters ONE
Wall Street Fundamentals Releases New In-Depth Stock Reports on DNDN, GERN, NKTR and NPSP 8:01 a.m. Aug. 12, 2013 - ACCESSWIRE
Geron Corporation Reports Second Quarter 2013 Financial Results 3:06 p.m. Aug. 8, 2013 - Thomson Reuters ONE
Geron Announces Conference Call to Discuss Second Quarter 2013 Financial Results 3:31 p.m. July 29, 2013 - Thomson Reuters ONE
Arena Pharma, Geron, Incyte, and Spectrum Pharma Under AAAResearchReports.com Microscope 9:56 a.m. July 29, 2013 - PR Newswire
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, GERN, IMMU and ITMN 7:48 a.m. July 2, 2013 - ACCESSWIRE
Early Morning Insight: Arena Pharmaceuticals, Geron, Celgene, Incyte, and Spectrum Pharmaceuticals 7:59 a.m. June 25, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

7-Eleven Rolls Out Korean Flavors in Bold Menu Shift

7-Eleven's New Global Menu Twist October 2026 sees 7-Eleven, Inc. whip out an intriguing move, venturing east with its new Flavors of Korea menu. They're not just changing the game in convenience store aisles; they're dancing to the beat of global flavors—a shake-up fit for the world's largest convenience retailer. Think about bodega basics getting a spicy Korean...

Air Force Enlisted Village: Trailblazing Senior Care

Changing the Senior Living Game for Military Families Out of all the fancy talk shows and slick productions, "All Access hosted by Andy Garcia" managed to hit a real nerve on the quiet, critical shifts happening in the senior living sector. They dug into how Air Force Enlisted Village in Shalimar is taking care of our military families' unsung heroes—the surviving...

JELD-WEN Kicks Off 2027 Senior Notes Exchange

By Caleb Price Updated Oct 28, 2026 Category News Views 164

A Fresh Play: Swapping Old for New With a fresh brew in hand and the latest company maneuvers on the table, JELD-WEN's move to exchange its 4.875% Senior Notes due 2027 for new secured notes maturing in 2031 comes into focus. This ain't just some routine shuffling of papers. They're calling up eligible folks holding onto those old notes, saying, 'Why stick with the old...

Max Stock Gears Up for Q3 Earnings Report Nov. 17

Max Stock's Q3 Earnings Anticipation Ah, it’s that time again—when we wait with bated breath for another round of quarterly earnings. Max Stock Ltd. (TASE: MAXO) is prepping to spill the beans on their third quarter 2026 performance, with a conference call scheduled for November 17. Big day? You bet. Who's Leading the Call? The brains behind the operation, CFO Paz Oz...

Aker BP's Q3 2026: Strong Earnings Fuel Optimism

Third Quarter Overview: Riding the Wave Aker BP's third quarter report is a raucous symphony of successes that have the market nodding in admiration. Marking significant strides with their offshore projects, the company seems to be in a cavalier mood as it boasts higher sales volumes and promising financials. Net production came in at 374 mboepd, dampened slightly by...

Pencil Reinvention Aims to Reduce Classroom Waste

Sharpen Those Ideas: Reinventing the Humble Pencil Every classroom has 'em: pencils chewed up faster than a kid chomping through bubblegum. This ain't new. But dig this—a Chicago teacher's coming in hot with a tweak to extend pencil life. How? By addressing the ol' crumbly eraser issue. You know, the kind that vanishes into thin air right when you need it most. So,...

Life Time's Q3 2026 Results Highlight Solid Growth

Life Time Rolls On With Strong Q3 Performance Sometimes the market hands you pure gold, and that's what Life Time (NYSE: LTH) has right now. They didn't just have a decent quarter; they outright nailed it with a $893.5 million total revenue haul—a hefty 14.2% rise from the prior year. What's driving this ship? Solid growth in membership dues and dynamic personal...

Bitcoin Mortgages: APX Ushers in New Canadian Era

Bitcoin Meets Canadian Mortgages: A Game Changer? Here's a scenario you didn't see coming: Bitcoin, the digital darling of the new millennium, now backing Canadian mortgages. If that doesn't get your financial senses tingling, maybe you haven't been paying attention. APX Lending, a pioneer in digital-asset-backed lending, is kicking open the doors to a fresh financial...

Cohere's CAD $7 Billion Raise Signals AI Power Shift

Changing the Game: Cohere's Massive Series E Raise There's a seismic shift happening up north, and it’s not the aurora borealis. Cohere just announced the initial close of a staggering CAD $7 billion Series E funding round, eyeing a CAD $35.7 billion valuation. If it pans out, it’d be the kind of cash grab that's never been seen in Canadian tech history. Why This...

CallRail's New Insight Tool: Navigating the Competitive Landscape

How CallRail's New Feature Changes the Game Ever sit in a boardroom meeting and wonder what your lead numbers really mean? CallRail just dropped a new feature that could change that. This AI-powered platform is now decking its 225,000 businesses with market insights to not just know their numbers but to understand how they stack up against their competition in the same...